Brokerages Favor Torrent Pharmaceuticals and Reliance Industries Amid Strong Growth Prospects
Buy, Sell or Hold: Citi keeps a buy on Torrent Pharmaceuticals; Morgan Stanley maintains overweight on Reliance Industries
The Economic Times
Image: The Economic Times
Brokerages are optimistic about Torrent Pharmaceuticals and Reliance Industries, citing strong growth visibility and attractive valuations. Citigroup maintains a 'buy' rating on Torrent, while Morgan Stanley favors Reliance due to resilient refining margins and improving prospects.
- 01Citigroup maintains a 'buy' rating on Torrent Pharmaceuticals.
- 02Torrent benefits from synergies from its acquisition of JB.
- 03Morgan Stanley favors Reliance Industries for its resilient refining margins.
- 04Both stocks are seen as having strong growth visibility.
- 05Improving margins and attractive valuations support these recommendations.
Advertisement
In-Article Ad
Brokerages are showing confidence in select pharmaceutical and energy stocks, particularly Torrent Pharmaceuticals and Reliance Industries. Citigroup has reiterated a 'buy' rating on Torrent Pharmaceuticals, highlighting the company's strong domestic growth prospects and synergies from its acquisition of JB. Meanwhile, Morgan Stanley has maintained an 'overweight' rating on Reliance Industries, citing resilient refining margins and improving business prospects. Both companies are viewed favorably due to their strong growth visibility and attractive valuations, making them preferred picks in their respective sectors.
Advertisement
In-Article Ad
Advertisement
In-Article Ad
More about Citigroup
Read the original article
Visit the source for the complete story.